CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Since CD34 considered as CML initiating cells [20], we then analyzed the expression levels by western blot, the results showed that the expression of CD34 levels were significantly reduced upon metformin treatment which demonstrates that metformin has potential to kill even CML initiating cells (Fig. 6F).